Search

everythinglearnresearchcommunity

for

Search:↓

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

Male hormones affect oil-producing skin cells differently based on their body location, and the drug spironolactone can reduce these effects.

Melatonin solution helps treat hair loss in men and women.

Androgen is important in controlling stem cell differentiation, reducing fat development, and increasing lean mass.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

No true link between AGA and insulin resistance, but coexistence may worsen AGA.

Hair loss linked to metabolic issues and insulin resistance; early assessment may reduce future health risks.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

Higher aldosterone levels link to hair loss and high blood pressure.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

The antiandrogen 11α-hydroxyprogesterone effectively reduces skin oil and cholesterol when applied to the skin.

Taking spironolactone and linestrenol for androgen excess can lead to lower bone density in young women.

People with hair loss may have different levels of certain hormones due to changes in hormone processing.

AR gene not major factor in female hair loss; different from male hair loss.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

Male hormones indirectly affect skin cell development by increasing growth factor levels from skin fibroblasts.

Finasteride may increase erectile dysfunction risk in patients with benign prostatic hyperplasia.

Ganoderma lucidum may help treat prostate cancer by blocking male hormones and slowing cancer cell growth.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

The N363S gene variant does not cause higher adrenal androgen levels in women with polycystic ovary syndrome.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

A drug called cimetidine can help treat hair loss in women by blocking androgen receptors. However, it's not the first choice and needs more research.

Finasteride works better for hair loss in patients 26 or younger.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

Fluridil safely promotes hair growth in men with androgenetic alopecia.

Balding men have higher heart disease risk.

Oxidative stress, not insulin resistance, is significantly related to free androgen index in PCOS.